MCRB – seres therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Seres Therapeutics, Inc. (NASDAQ: MCRB) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
The Athlete's Edge: How One Biotech Startup Is Mining Elite Athletes' Gut Bacteria To Create Next-Gen Probiotics [Forbes]
Seres Therapeutics, Inc. (NASDAQ: MCRB) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $10.00 price target on the stock.
Seres Therapeutics Inc (MCRB) Q3 2024 Earnings Call Highlights: Strategic Moves and Clinical ... [Yahoo! Finance]
Seres Therapeutics, Inc. (NASDAQ: MCRB) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $1.25 price target on the stock.
Form 4 Seres Therapeutics, Inc. For: Nov 15 Filed by: DesRosier Thomas
Form 4 Seres Therapeutics, Inc. For: Nov 15 Filed by: von Moltke Lisa
Form 4 Seres Therapeutics, Inc. For: Nov 15 Filed by: Shaff Eric D.
Form 4 Seres Therapeutics, Inc. For: Nov 15 Filed by: Young Teresa L.
Form 4 Seres Therapeutics, Inc. For: Nov 15 Filed by: Henn Matthew R.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.